™Your Policy Risk Impact Agent
24 chapters · 1,542 sections in this title.
KRS § 218A.513 Ibogaine research and intellectual property fund
1.1K chars
(1) There is hereby established in the State Treasury a trust and agency fund entitled the ibogaine research and intellectual property fund, to be administered by the department for the purpose of allowing the department to enter into a public-private partnership with a drug deve…
KRS § 218A.515 Requirements for contract between department and drug developer -- Intellectual property rights and other commercial rights
3.8K chars
Intellectual property rights and other commercial rights. (1) Before the department may contract with a drug developer, the drug developer shall provide the department with: (a) A detailed description of the drug developer’s strategy for obtaining approval for the drug developmen…
KRS § 218A.517 Drug developer to report quarterly to department -- Department to submit annual report to LRC
0.7K chars
submit annual report to LRC. (1) The drug developer shall quarterly prepare and submit to the department a: (a) Report on the progress of any multistate drug development clinical trials with ibogaine conducted pursuant to KRS 218A.511 to 218A.519; and (b) Financial status report,…
KRS § 218A.519 Deposits and expenditures for ibogaine research and intellectual property fund
0.6K chars
property fund. All receipts from the proceeds from the commercialization of intellectual property created through the public-private partnership created under KRS 218A.511 to 218A.519 shall be deposited into the ibogaine research and intellectual property fund established in KRS …